What is GenTarget?
GenTarget Inc. is a San Diego-based biotechnology firm specializing in the development and provision of lentivirus products and related gene editing tools. The company's offerings encompass a broad spectrum of research and development solutions, including premade lentivirus, CRISPR gene editing technologies, and custom stable cell lines. GenTarget serves clients within the genetic engineering and cellular biology sectors, supporting critical research initiatives.
How much funding has GenTarget raised?
GenTarget has raised a total of $16K across 1 funding round:
Debt
$16K
Debt (2021): $16K with participation from PPP
Key Investors in GenTarget
PPP
Public-Private Partnership
What's next for GenTarget?
With the recent capital injection, GenTarget is poised for a significant growth phase, likely focusing on scaling its product development and expanding its market reach within the R&D sector. The Series A/B growth stage funding suggests a strategic move towards commercialization and increased operational capacity, potentially involving further technological advancements in lentivirus and CRISPR applications.
See full GenTarget company page
